Medication‐induced obstructive uropathy and hyperprolactinemia in a pediatric patient | Zendy

NkansahAmankra Kwabena | Zendy; Sudhanthar Sathyanarayan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Medication‐induced obstructive uropathy and hyperprolactinemia in a pediatric patient

Author(s) -

NkansahAmankra Kwabena,

Sudhanthar Sathyanarayan

Publication year - 2019

Publication title -

clinical case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.21

H-Index - 9

ISSN - 2050-0904

DOI - 10.1002/ccr3.2396

Subject(s) - medicine , obstructive uropathy , prolactin , etiology , bromocriptine , dopamine , obstructive hydrocephalus , pituitary stalk , drug , intensive care medicine , pediatrics , endocrinology , pituitary gland , urinary system , surgery , pharmacology , hydrocephalus , hormone

Hyperprolactinemia can result from a pituitary tumor or decreased dopamine levels due to compression of the pituitary stalk. Hypothyroidism, renal failure, and drug interaction need to be ruled out as a part of diagnostic evaluation. The prolactin level often indicates the etiology, but drug interaction needs to be ruled out mainly in a patient who is on multiple medications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research